Abstract:BRCA1 mutation carriers have an increased susceptibility to breast and ovarian cancer. Excision of exon 11 of Brca1 in the mouse, using a conditional knockout (Cre-loxP) approach, results in mammary tumor formation after long latency. To characterize the genomic instability observed in these tumors, to establish a comparative map of chromosomal imbalances and to contribute to the validation of this mouse model of breast cancer, we have characterized chromosomal imbalances and aberrations using comparative genomic hybridization (CGH), and spectral karyotyping (SKY). We found that all tumors exhibit chromosome instability as evidenced by structural chromosomal aberrations and aneuploidy, yet they display a pattern of chromosomal gain and loss that is similar to the pattern in human breast carcinomas. Of note, nine of 15 tumors exhibited a gain of distal chromosome 11, a region that is orthologous to human chromosome 17q11-qter, the mapping position of Erbb2. However, our analysis suggests that genes distal to Erbb2 are the main targets of amplification. Four of the tumors also exhibited a copy number loss of proximal chromosome 11 (11A-B), a region orthologous to human 17p. In eight of the tumors we observed whole or partial gain of chromosome 15 centering on 15D2-D3 (orthologous to human chromosome 8q24), the map location of the c-Myc gene, and six of the tumors exhibited copy number loss of whole or partial chromosome 14, including 14D3, the map location of Rb1. We conclude that despite the tremendous shuffling of chromosomes during the course of mammalian evolution, the pattern of genomic imbalances is conserved between BRCA1-associated mammary gland tumors in mice and humans. Western blot analysis showed that while p53 is absent or mutated in some tumors, at least two tumors revealed wild-type protein, suggesting that other genetic events may lead to tumorigenesis. Similar to BRCA1-deficient mouse embryonic fibroblasts, the tumor cells contained supernumerary functional centrosomes with intact centrioles whose presence results in multipolar mitoses and aneuploidy.

Tumor Formation in Mice with Conditional Inactivation of Brca1 in Epithelial Tissues.

Tumor formation inBrca1 conditional mutant mice

Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice

Mouse Models for BRCA1-associated Breast Cancer

Conditional Mutation of Brca1 in Mammary Epithelial Cells Results in Blunted Ductal Morphogenesis and Tumour Formation

Hyperplasia and Spontaneous Tumor Development in the Gynecologic System in Mice Lacking the BRCA1-Δ11 Isoform

Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer

Mammary Tumors in Mice Conditionally Mutant for Brca1 Exhibit Gross Genomic Instability and Centrosome Amplification Yet Display a Recurring Distribution of Genomic Imbalances That is Similar to Human Breast Cancer

Expression of Brca1 is Associated with Terminal Differentiation of Ectodermally and Mesodermally Derived Tissues in Mice.

Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice

Brca1 Suppresses Epithelial-To-Mesenchymal Transition And Stem Cell Dedifferentiation During Mammary And Tumor Development

BRCA1 Regulates Human Mammary Stem/progenitor Cell Fate

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

Role of the Tumor Suppressor Gene Brca1 in Genetic Stability and Mammary Gland Tumor Formation.

pRb Inactivation in Mammary Cells Reveals Common Mechanisms for Tumor Initiation and Progression in Divergent Epithelia

Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer

A Targeted Disruption of the Murine Brca1 Gene Causes Γ-Irradiation Hypersensitivity and Genetic Instability

Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells.

BRCA1 and homologous recombination: implications from mouse embryonic development

Uterus Hyperplasia and Increased Carcinogen-Induced Tumorigenesis in Mice Carrying a Targeted Mutation of the Chk2 Phosphorylation Site in Brca1

Loss of Function of BRCA1 Promotes EMT in Mammary Tumors Through Activation of TGFβR2 Signaling Pathway